...
首页> 外文期刊>Neurorehabilitation and neural repair >Clinical and Psychometric Evaluations of the Cerebral Vision Screening Questionnaire in 461 Nonaphasic Individuals Poststroke
【24h】

Clinical and Psychometric Evaluations of the Cerebral Vision Screening Questionnaire in 461 Nonaphasic Individuals Poststroke

机译:461名非全相中风后脑视力筛查问卷的临床和心理计量学评估

获取原文
获取原文并翻译 | 示例
           

摘要

Background. Cerebral vision disorders (CVDs) are frequent after brain damage and impair the patient's outcome. Yet clinically and psychometrically validated procedures for the anamnesis of CVD are lacking. Objective. To evaluate the clinical validity and psychometric qualities of the Cerebral Vision Screening Questionnaire (CVSQ) for the anamnesis of CVD in individuals poststroke. Methods. Analysis of the patients' subjective visual complaints in the 10-item CVSQ in relation to objective visual perimetry, tests of reading, visual scanning, visual acuity, spatial contrast sensitivity, light/dark adaptation, and visual depth judgments. Psychometric analyses of concurrent validity, specificity, sensitivity, positiveegative predictive value, and interrater reliability were also done. Results. Four hundred sixty-one patients with unilateral (39.5% left, 47.5% right) or bilateral stroke (13.0%) were included. Most patients were assessed in the chronic stage, on average 36.7 (range = 1-620) weeks poststroke. The majority of all patients (96.4%) recognized their visual symptoms within 1 week poststroke when asked for specifically. Mean concurrent validity of the CVSQ with objective tests was 0.64 (0.54-0.79, P < .05). The mean positive predictive value was 80.1%, mean negative predictive value 82.9%, mean specificity 81.7%, and mean sensitivity 79.8%. The mean interrater reliability was 0.76 for a 1-week interval between both assessments (all P < .05). Conclusion. The CVSQ is suitable for the anamnesis of CVD poststroke because of its brevity (10 minute), clinical validity, and good psychometric qualities. It, thus, improves neurovisual diagnosis and guides the clinician in the selection of necessary assessments and appropriate neurovisual therapies for the patient.
机译:背景。脑损伤后经常发生脑视觉障碍(CVD),损害患者的预后。然而,尚缺乏用于CVD回忆的临床和心理计量学验证程序。目的。评估脑卒中后脑卒中的脑视觉筛查问卷(CVSQ)的临床有效性和心理计量学质量。方法。在10个项目的CVSQ中分析患者的主观视觉不适,包括客观视觉视野,阅读测试,视觉扫描,视敏度,空间对比敏感度,明暗适应性和视觉深度判断。还对并发有效性,特异性,敏感性,阳性/阴性预测值和间位信度进行了心理计量学分析。结果。纳入461例单侧(左39.5%,右47.5%)或双侧中风(13.0%)的患者。大多数患者在中风后平均36.7周(范围= 1-620)的慢性阶段进行评估。当特别要求时,所有患者中的大多数(96.4%)在中风后1周内认识到了他们的视觉症状。 CVSQ的客观检验的平均并发有效性为0.64(0.54-0.79,P <.05)。平均阳性预测值为80.1%,平均阴性预测值为82.9%,平均特异性为81.7%,平均敏感性为79.8%。两次评估之间的1周间隔内,平均间位可靠度为0.76(所有P <.05)。结论。 CVSQ的简短(10分钟),临床有效性和良好的心理测验质量使其适合于CVD中风后的回忆。因此,它改善了神经视觉诊断并指导临床医生为患者选择必要的评估和适当的神经视觉疗法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号